E-LIB Suche - Ergebnisse für: Brannan, Stephen K.

1

414. Understanding the Role of Muscarinic M1 and M4 Recepto..:

Yohn, Samantha E. ; Horan, William P. ; Brannan, Stephen K..
Biological Psychiatry. 95 (2024) 10 - p. S269-S270 , 2024

Link: https://doi.org/10.1016/..

2

Muscarinic Receptor Activators as Novel Treatments for Schi..:

Paul, Steven M. ; Yohn, Samantha E. ; Brannan, Stephen K...
Biological Psychiatry. , 2024

Link: https://doi.org/10.1016/..

3

412. Efficacy of Karxt on Negative Symptoms in Acute Schizo..:

Horan, William ; Claxton, Amy ; Targum, Steven D....
Biological Psychiatry. 95 (2024) 10 - p. S268-S269 , 2024

Link: https://doi.org/10.1016/..

4

Efficacy and safety of the muscarinic receptor agonist KarX..:

Kaul, Inder ; Sawchak, Sharon ; Correll, Christoph U...
The Lancet. 403 (2024) 10422 - p. 160-170 , 2024

Link: https://doi.org/10.1016/..

5

Evidence of trospium's ability to mitigate cholinergic adve..:

Breier, Alan ; Brannan, Stephen K. ; Paul, Steven M..
Psychopharmacology. 240 (2023) 5 - p. 1191-1198 , 2023

Link: https://doi.org/10.1007/..

6

Safety and efficacy of KarXT (Xanomeline Trospium) in Schiz..:

Correll, Christoph U. ; Miller, Andrew C. ; Sawchak, Sharon...
CNS Spectrums. 28 (2023) 2 - p. 220-220 , 2023

Link: https://doi.org/10.1017/..

7

183. Understanding the Role of M1 and M4 Muscarinic Recepto..:

Yohn, Samantha E. ; Sauder, Colin ; Paul, Steven M..
Biological Psychiatry. 93 (2023) 9 - p. S167-S168 , 2023

Link: https://doi.org/10.1016/..

8

Effectiveness of KarXT (xanomeline-trospium) for cognitive ..:

Sauder, Colin ; Allen, Luke A. ; Baker, Elizabeth...
Translational Psychiatry. 12 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

9

Safety and tolerability of KarXT (xanomeline–trospium) in a..:

Correll, Christoph U. ; Angelov, Angel S. ; Miller, Andrew C...
Schizophrenia. 8 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

10

Site-independent confirmation of primary site-based PANSS r..:

Targum, Steven D. ; Murphy, Christopher ; Breier, Alan.
Journal of Psychiatric Research. 144 (2021) - p. 241-246 , 2021

Link: https://doi.org/10.1016/..

11

The TOMMORROW study: Design of an Alzheimer's disease delay..:

Burns, Daniel K. ; Chiang, Carl ; Welsh‐Bohmer, Kathleen A....
Alzheimer's & Dementia: Translational Research & Clinical Interventions. 5 (2019) 1 - p. 661-670 , 2019

Link: https://doi.org/10.1016/..

12

Effects of pioglitazone on mnemonic hippocampal function: A..:

Knodt, Annchen R. ; Burke, James R. ; Welsh‐Bohmer, Kathleen A....
Alzheimer's & Dementia: Translational Research & Clinical Interventions. 5 (2019) 1 - p. 254-263 , 2019

Link: https://doi.org/10.1016/..

13

A call for comparative effectiveness research to learn whet..:

Dacks, Penny A. ; Armstrong, Joshua J. ; Brannan, Stephen K....
Alzheimer's Research & Therapy. 8 (2016) 1 - p. , 2016

Link: https://doi.org/10.1186/..

14

P2‐083: Progress in the tommorrow study: A pharmacogenetics..:

Budur, Kumar ; Welsh-Bohmer, Kathleen ; Burns, Daniel K....
Alzheimer's & Dementia. 11 (2015) 7S_Part_11 - p. , 2015

Link: https://doi.org/10.1016/..

15

New applications of disease genetics and pharmacogenetics t..:

Roses, Allen D ; Saunders, Ann M ; Lutz, Michael W...
Current Opinion in Pharmacology. 14 (2014) - p. 81-89 , 2014

Link: https://doi.org/10.1016/..